课题基金 / 基金详情

Analysis of transcriptional control mechanism for the expression of type I collagen gene in fibrotic skin disorders

Analysis of transcriptional control mechanism for the expression of type I collagen gene in fibrotic skin disorders
纤维化皮肤病中 I 型胶原基因表达的转录控制机制分析
批准号:
10670779
负责人:
HATAMOCHI Atsushi
金额:
$1.73万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000

项目摘要

项目成果

HATAMOCHI Atsushi的其他基金

相似基金

相关文献

中文摘要
翻译
I型胶原是真皮中含量最多的蛋白,由两条α1(I)链和一条α 2(I)链协调表达组成。ColF1是一种特异性结合α2(I)胶原启动子片段的DNA结合蛋白,位于α2(I)胶原基因转录起始上游-400bp处,在体外激活α2(I)胶原基因的转录,由两种多肽组成。我们对α2(I)胶原基因转录因子的cDNA克隆进行了研究。结果发现,42kDa多肽与Pur α相同,是一个已报道与人类c-mye基因上游区域结合的核蛋白;40kDa多肽与Pur β相同,已部分测序,与Pur α具有较强的同源性。对Pur β cDNA进行全长测序。我们在体内寻找表达异常水平胶原蛋白的成纤维细胞作为I型胶原基因转录控制机制的模型系统。我们发现两株Ehlers-Danlos综合征成纤维细胞产生极低水平的III型胶原蛋白。
英文摘要
Type I collagen, a most abundant protein in the dermis, consists of two α1(I) chain and one α 2(I) chain which are coordinately expressed. ColF1, a DNA binding protein which specifically binds to a segment of the α2(I) collagen promoter at -400bp upstream of the start of transcription, activates transcription of the α2(I) collagen gene in vitro, and consists of two polypeptides. We investigated on the the cDNA cloning of this transcriptional factor of the α2(I) collagen gene. We found that 42kDa polypeptide were identical to Pur α, is a nuclear protein which has been reported to binds to a upstream region of human c-mye gene, and 40kDa polypeptide were identical to Pur β, has been partially sequenced and has regions of strong homology to Pur α. Full length of Pur β cDNA were sequenced. We had looked for fibroblasts express abnormal levels of collagen as model systems of transcriptional control mechanisms of type I collagen gene in vivo. We found two strains of Ehlers-Danlos syndrome fibroblasts which produced extremely low levels of type III collagen.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
Hatamochi A,: "Costello Syndrome with Decreased Gene Expression of Elastin in Cultured Dermal Fibroblasts."Dermatology.. 201(4). 366-369 (2000)
Hatamochi A,:“培养的真皮成纤维细胞中弹性蛋白基因表达降低的科斯特洛综合征。”皮肤病学.. 201(4)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hatamochi, A.: "Costello syndrome with decreased gene expression of elastin in cultured dermal fibroblasts"Dermatology. 201. 366-369 (2000)
Hatamochi, A.:“培养的真皮成纤维细胞中弹性蛋白基因表达降低的 Costello 综合征”皮肤病学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hatamodri,A.: "Regulation of matrix metalloproteinase (MMP) expression in cutis laxa fibroblasts : upregulation of MMP-1, -3 and -9 genes but not-2 gen"Brit J Dermatol. 138(5). 757-762 (1998)
Hatamodri,A.:“皮肤松弛成纤维细胞中基质金属蛋白酶 (MMP) 表达的调节:MMP-1、-3 和 -9 基因的上调,但不是 2 基因的上调”Brit J Dermatol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tsukifuji, R.: "Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis"Brit J Cancer. 80. 1087-1091 (1999)
Tsukifuji, R.:“鳞状细胞癌和光化性角化病中基质金属蛋白酶-1、-2和-3的表达”Brit J Cancer。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 13 条
    Analysis of the genetic and phenotypic findings in Japanese patients with vascular-type Ehlers-Danlos syndrom
    • 批准号:
      21591442
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.25万
    • 财政年份:
      2009
    • 负责人:
      HATAMOCHI Atsushi
    • 依托单位:
    Analysis of transcriptional control mechanism for the expression of type I collagen and related gene in fibrotic skin disorders
    Transcriptional control mechanism for the expression of type I collagen gene in fibrotic skin disorders and related diseases
    • 批准号:
      08670948
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.41万
    • 财政年份:
      1996
    • 负责人:
      HATAMOCHI Atsushi
    • 依托单位:
    Transcriptional control mechanism for the expression of alpha1 (1) collagen gene in fibrotic skin disorders
    国内基金
    海外基金
    利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
    • 批准号:
      82371145
    • 项目类别:
      面上项目
    • 资助金额:
      46.00万元
    • 批准年份:
      2023
    • 负责人:
      陶永
    • 依托单位:
    转录因子BCL6抑制ICOSL表达优化生发中心反应的机制研究
    • 批准号:
      82371745
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      张文倩
    • 依托单位:
    转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
    • 批准号:
      82371704
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      徐步芳
    • 依托单位:
    小鼠肺腺鳞癌转分化类器官模型的建立及表观调控分子机制研究